Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Kidney International|January 13, 2021
Management of acute kidney injury in symptomatic multiple myelomaFrank Bridoux, Nelson Leung, Mohamed Belmouaz, et al.
Kidney Medicine|July 26, 2023
Kidney Biopsy Findings Among Allogenic Hematopoietic Stem Cell Transplant Recipients With Kidney Injury: A Case SeriesGuillaume Roy, Ilinca Iordachescu, Virginie Royal, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 18, 2023
A Comprehensive Multidisciplinary Diagnostic Algorithm for the Early and Efficient Detection of AmyloidosisVictor Jimenez-Zepeda, Vera Bril, Emilie Lemieux-Blanchard, et al.
Pathology, Research and Practice|October 4, 2017
Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumorsRola M Saleeb, John R Srigley, Joan Sweet, et al.
American Journal of Physiology. Cell Physiology|December 1, 2021
Subchronic oral exposure of tungsten induces myofibroblast transformation and various markers of kidney fibrosisMichael P Grant, Nathalie Henley, Marion Dubuissez, et al.
American Journal of Nephrology|February 19, 2026
Immune Deposits, Complement Activation and APOL1 Risk variants in Focal Segmental GlomerulosclerosisYasar Caliskan, Virginie Royal, Stéphan Troyanov, et al.
Scientific Reports|August 6, 2020
Alk1 haploinsufficiency causes glomerular dysfunction and microalbuminuria in diabetic miceCindy Lora Gil, Nathalie Henley, François A Leblond, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2014
IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometryVirginie Royal, Patrick Quint, Martine Leblanc, et al.
Kidney360|April 1, 2025
Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the CureGN StudyYasar Caliskan, Virginie Royal, Stéphan Troyanov, et al.
Pageof 5